Novel compound has promise for treatment of Huntington’s disease

A multi-institutional study has identified a promising treatment strategy for Huntington’s disease (HD). The novel compound appears to protect against neurodegeneration in cellular and animal models of HD by means of two separate mechanisms — inhibiting the regulatory enzyme SIRT2 and activating the antioxidant pathway controlled by the NRF2 transcription factor.